Table 2.
Selection | Comparability | Outcome | Overall quality | |||||
Observational studies1 | ||||||||
Ahmad et al[13] | ++ | + | ++ | 5 | ||||
Kooby et al[14] | +++ | ++ | ++ | 7 | ||||
Carr et al[15] | ++ | ++ | ++ | 6 | ||||
Salem et al[16] | ++++ | ++ | +++ | 9 | ||||
Lance et al[17] | +++ | ++ | ++ | 7 | ||||
Moreno-Luna et al[18] | ++++ | ++ | +++ | 9 | ||||
El Fouly et al[20] | ++ | + | +++ | 6 | ||||
Akinwande et al[22] | ++ | + | ++ | 5 | ||||
Randomized controlled trials2 | ||||||||
1 | 2 | 3 | 4 | 5 | 6 | 7 | ||
Pitton et al[19] | L | L | L | U | L | L | L | H |
Kolligs et al[21] | L | H | U | U | H | L | L | M |
Study quality assessment performed by means of Newcastle/Ottawa scale (each asterisk represents if the respective criterion within the subsection was satisfied);
Cochrane Collaboration’s tool for assessing the risk of bias across 7 domains: (1) random sequence generation; (2) allocation concealment; (3) blinding of participants and personnel; (4) blinding of outcome assessment; (5) incomplete outcome data; (6) selective reporting; and (7) other bias. L: Low; H: High; U: Unclear; M: Moderate.